Outcome attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited standalone financial results for Q3 and nine months ended December 31, 2025, along with the limited review report by HSK & Co LLP. Revenue from operations is reported as nil for both Q3 FY26 and 9M FY26, with only 'Other Income' of Rs. 4.98 lakhs in Q3 FY26 (down sharply from Rs. 30.33 lakhs in Q3 FY25) and Rs. 61.77 lakhs for 9M FY26 (vs Rs. 92.73 lakhs in 9M FY25). The company swung to a quarterly loss with PAT of Rs. (5.06) lakhs in Q3 FY26, compared to a profit of Rs. 12.21 lakhs in Q3 FY25. For 9M FY26, PAT stood at Rs. 17.19 lakhs, down about 42% from Rs. 29.86 lakhs in 9M FY25, while EPS dropped to Rs. 0.20 from Rs. 0.35. Finance costs remain a significant drag at Rs. 27.57 lakhs for 9M FY26.
Negative for shareholders — the company has effectively zero revenue from operations and posted a quarterly loss, signaling operational stress. The sharp decline in income and earnings may weigh on the stock and raises questions about the sustainability of the business.